Evidence map›Paper›PMID 42241378›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2026

[Clinical and obstetric characteristics in women with multiple sclerosis during pregnancy].

Erick René Nava-Escobar, Mario Alberto Mireles-Ramírez, Blanca Miriam Torres-Mendoza, Martha Rocío Hernández-Preciado, Nayeli Alejandra Sánchez-Rosales, Jazmin Márquez-Pedroza

Abstract readEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erick René Nava-EscobarInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio Téllez", Servicio de Neurología. Guadalajara, Jalisco, México.ORCID 0000-0003-2616-2465
Mario Alberto Mireles-RamírezInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio Téllez", División de Educación e Investigación. Guadalajara, Jalisco, México.ORCID 0000-0002-8321-7883
Blanca Miriam Torres-MendozaInstituto Mexicano del Seguro Social, Centro de Investigación Biomédica de Occidente, División de Neurociencias. Guadalajara, Jalisco, México.ORCID 0000-0003-2233-571X
Martha Rocío Hernández-PreciadoInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio Téllez", División de Educación e Investigación. Guadalajara, Jalisco, México.ORCID 0000-0003-4757-4792
Nayeli Alejandra Sánchez-RosalesInstituto Mexicano del Seguro Social, Centro Médico Nacional de Occidente, Hospital de Especialidades "Lic. Ignacio Téllez", Servicio de Neurología. Guadalajara, Jalisco, México.ORCID 0000-0003-4297-7111
Jazmin Márquez-PedrozaInstituto Mexicano del Seguro Social, Centro de Investigación Biomédica de Occidente, División de Neurociencias. Guadalajara, Jalisco, México.ORCID 0000-0003-2859-726X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple sclerosis (MS) is an inflammatory demyelinating disease that affects the central nervous system. It is the second leading cause of disability in young adults, with a higher prevalence in women, and 70% to 75% of these women are of reproductive age. Objective: To identify the clinical characteristics of pregnant patients with multiple sclerosis. Material and methods: Retrospective cohort. Medical records from the Neurology Department of the Specialty Hospital, CMNO of the Mexican Social Security Institute were reviewed from January 2001 to December 2022. Women diagnosed with MS who had previously been pregnant were identified. Results: Twenty-two patients who had been pregnant after their MS diagnosis were recruited. The age at diagnosis was 25.50 ± 6.7 years, and the age at pregnancy was 31.94 ± 5.54 years. No significant changes (p = 0.636) were observed on the Expanded Disability Status Scale (EDSS) during pregnancy. The most used medication was glatiramer acetate. 77.8% of patients did not experience disease relapses during pregnancy. Conclusions: Pregnant women with multiple sclerosis treated at the National Western Medical Center showed clinical stability according to the EDSS before, during, and after pregnancy (p = 0.636). Most patients did not experience disease relapses during pregnancy, nor did they report complications during the immediate postpartum period.

Indexed as

Multiple SclerosisPregnancy ComplicationsAdultFemaleGlatiramer AcetateHumansMexicoPregnancyRetrospective StudiesYoung AdultGlatiramer AcetateComplicaciones del EmbarazoDrug TherapyEsclerosis MúltipleFarmacoterapiaÍndice de EmbarazoMultiple SclerosisPregnancy ComplicationsPregnancy Rate

Identifiers

PMID42241378
PMCPMC13275042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.